Insulin Dosing for Pediatric DKA
For children with diabetic ketoacidosis, administer continuous intravenous insulin infusion at 0.05-0.10 units/kg/hour without an initial bolus, with growing evidence supporting the lower dose of 0.05 units/kg/hour for enhanced safety. 1
Standard Dosing Protocol
Initial Insulin Administration
- Start continuous IV insulin infusion at 0.05-0.10 units/kg/hour using regular insulin 1
- Do NOT give an initial IV bolus in pediatric patients - this is explicitly not recommended for children, unlike adults 2
- For neonates specifically: use 0.05 units/kg/hour 1
Monitoring and Titration
- Monitor blood glucose and potassium hourly or more frequently as needed 1
- Target glucose decline: 50-100 mg/dL per hour 1
- If glucose doesn't fall by 50 mg/dL in the first hour, verify adequate hydration, then double the insulin infusion rate hourly until achieving steady glucose decline of 50-75 mg/dL per hour 2
Glucose Management During Treatment
- When blood glucose reaches 250 mg/dL, add 5% dextrose to IV fluids 2
- Continue insulin infusion to clear ketosis - ketonemia takes longer to resolve than hyperglycemia 2
- Maintain insulin infusion until ketoacidosis resolves, not just until glucose normalizes
Evidence for Lower-Dose Insulin (0.05 units/kg/hour)
Recent high-quality evidence strongly supports using the lower end of the dosing range:
Safety Advantages
A 2025 systematic review and meta-analysis 3 demonstrated that 0.05 units/kg/hour compared to 0.1 units/kg/hour significantly reduces:
- Hypoglycemia risk by 61% (RR 0.39,95% CI: 0.18-0.88)
- Hypokalemia risk by 46% (RR 0.54,95% CI: 0.33-0.89)
A 2023 meta-analysis 4 confirmed these findings with moderate certainty evidence showing:
- Reduced hypoglycemia (RR 0.37,95% CI: 0.15-0.80)
- Reduced hypokalemia (RR 0.65,95% CI: 0.47-0.89)
Equivalent Efficacy
Both doses achieve comparable metabolic correction 3, 4:
- No significant difference in time to acidosis resolution
- No difference in time to hyperglycemia resolution
- No difference in mortality or cerebral injury rates
- No difference in hospital length of stay
A 2026 RCT 5 showed time to acidosis resolution was identical (10.2 vs 11.2 hours, p=0.407) while the lower dose used 50% less total insulin.
Critical Safety Considerations
Hypokalemia Prevention
Never start insulin if potassium <3.3 mEq/L 2 - this is an absolute contraindication. Correct hypokalemia first with potassium replacement.
Fluid Management Integration
Appropriate fluid and electrolyte therapy is essential and arguably more important than insulin dosing for preventing cerebral edema 1. The insulin infusion works synergistically with rehydration - insulin alone is insufficient.
Subcutaneous Insulin Alternative
For mild DKA only, subcutaneous regular insulin at 0.25-0.50 units/kg per dose may be considered 1, though continuous IV infusion remains preferred for moderate-to-severe cases.
Practical Algorithm
- Confirm potassium ≥3.3 mEq/L before starting insulin
- Start regular insulin IV infusion at 0.05 units/kg/hour (no bolus)
- Check glucose and potassium hourly
- If glucose decline <50 mg/dL in first hour → verify hydration → double insulin rate
- At glucose 250 mg/dL → add 5% dextrose to IV fluids, continue insulin
- Continue insulin until ketoacidosis resolves (pH >7.3, bicarbonate >15 mEq/L)
Common Pitfalls
- Giving an initial bolus - this increases hypoglycemia risk without benefit in children
- Stopping insulin when glucose normalizes - ketoacidosis persists longer than hyperglycemia; continue insulin with dextrose supplementation
- Using 0.1 units/kg/hour routinely - the lower dose (0.05 units/kg/hour) provides equal efficacy with better safety profile
- Inadequate potassium monitoring - hypokalemia is a major complication that worsens with insulin therapy
The evidence strongly favors starting at 0.05 units/kg/hour for most pediatric DKA cases, reserving higher doses only for situations where glucose decline is inadequate despite confirmed adequate hydration.